Recent Posts

Citing Liver Damage, Pfizer Withdraws Thelin
Posted on 10 Dec 2010 by LexisNexis Litigation Resource Community Staff

NEW YORK - (AP) Pfizer Inc. said Friday it is pulling its blood pressure drug Thelin off the market and stopping all clinical trials because the drug can cause fatal liver damage . Thelin is sold in the European Union, Canada, and Australia as an oral... Read More